February 13, 2020

Potentially highly potent drugs for 2019-nCoV

Category: Article Summary

Topic: Public Health Policy and Practice

• Researchers reviewed 1,465 FDA-approved drugs for potential efficacy in treating COVID-19, quantifying binding affinity and using machine learning methods. The highest scoring options were Bortezomib, Flurazepam, and Ponatinib.

Nguyen et al. (Feb 5, 2020). Potentially highly potent drugs for 2019-nCoV. Pre-print downloaded Feb 13 from https://www.biorxiv.org/content/10.1101/2020.02.05.936013v1